Yooma Wellness Inc. (LVVEF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2021 | 2020 | 2019 |
|---|---|---|---|
| Operating Cash Flow | -10.96 Million | -2.06 Million | -3.22 Million |
| Net Income | -33.11 Million | -4.81 Million | -11.12 Million |
| Depreciation & Amortization | 912.46 Thousand | 17.35 Thousand | 9636.60 |
| Deferred income taxes | -214.89 Thousand | -17.35 Thousand | - |
| Stock-based compensation | 670.2 Thousand | - | 770.32 Thousand |
| Change in working capital | -2.29 Million | 266.79 Thousand | 157.05 Thousand |
| Other non-cash items | 23.07 Million | 1.67 Million | 6.96 Million |
| Investing Cash Flow | 481.8 Thousand | -218.93 Thousand | -279.38 Thousand |
| Investments in PPE | - | - | -7097.31 |
| Acquisitions | 351.05 Thousand | - | 0.96 |
| Investment purchases | - | -520.14 Thousand | -3.29 Million |
| Sales/Maturities of investments | - | 301.2 Thousand | 2.95 Million |
| Other Investing Activities | 130.75 Thousand | 0.42 | 71.16 Thousand |
| Financing Cash Flow | 9.28 Million | -53.07 Thousand | - |
| Debt repayment | -543.86 Thousand | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 9.83 Million | - | - |
| Other Financing Activities | - | -53.07 Thousand | - |
| Accounts receivables | -790.09 Thousand | - | - |
| Accounts payables | -4.14 Million | - | - |
| Inventory | 133.73 Thousand | - | - |
| Other working capital | 2.5 Million | - | - |
| Cash at beginning of period | 2.48 Million | 6.94 Million | 10.28 Million |
| Cash at end of period | 1.23 Million | 4.61 Million | 6.78 Million |
| Capital Expenditure | - | - | -7097.31 |
| Effect of forex changes on cash | -50.68 Thousand | - | - |
| Net cash flow / Change in cash | -1.24 Million | -2.33 Million | -3.5 Million |
| Free Cash Flow | -10.96 Million | -2.06 Million | -3.23 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | - | -624.82 Thousand | -1.12 Million |
| Depreciation & Amortization | - | - | - | - | 33.45 Thousand | 71.43 Thousand |
| Deferred income taxes | - | - | - | - | -29.73 Thousand | -196.01 Thousand |
| Stock-based compensation | - | - | - | - | 45.72 Thousand | 201.64 Thousand |
| Change in working capital | - | - | - | - | -67.82 Thousand | -401.77 Thousand |
| Other non-cash items | - | - | - | - | -554.73 Thousand | 703.78 Thousand |
| Investing Cash Flow | - | - | - | - | 100 Thousand | 2.34 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | 20.19 Thousand | 2.31 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 79.8 Thousand | 28.73 Thousand |
| Financing Cash Flow | - | - | - | - | 33.27 Thousand | -436.19 Thousand |
| Debt repayment | - | - | - | - | -133.27 Thousand | -436.19 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 166.55 Thousand | 399.46 |
| Accounts receivables | - | - | - | - | -226.21 Thousand | 387.71 Thousand |
| Accounts payables | - | - | - | - | -231.39 Thousand | -1.16 Million |
| Inventory | - | - | - | - | -372.52 Thousand | 788.1 Thousand |
| Other working capital | - | - | - | - | 762.3 Thousand | -407.75 Thousand |
| Cash at beginning of period | - | - | - | 720.56 Thousand | 1.79 Million | 624.41 Thousand |
| Cash at end of period | - | - | - | 720.56 Thousand | 725.73 Thousand | 1.79 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | 9352.00 |
| Net cash flow / Change in cash | - | - | - | - | -1.06 Million | 1.16 Million |
| Free Cash Flow | - | - | - | - | -1.19 Million | -749.12 Thousand |
AURWF
3600
2903
QCXGF
3662
IP